PATENT CLAIM ANALYSIS

Application Number: 15940055
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "092000"]

Abstract:
A pharmaceutical combination comprising a platinum-containing anticancer agent, and an Hsp90 inhibitor according to the following formulae (I) & (Ia), a tautomer, or a pharmaceutically acceptable salt thereof, wherein the variables structural formulae are defined herein. Also provided is a method of treating a proliferative disorder such as cancer in a subject in need thereof, using the pharmaceutical combination described herein.

Claim (Index 14):
The method of  claim 13 , wherein the method comprising administering a compound of 3-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(1-methyl-indol-5-yl)-5-hydroxy-[1,2,4]triazole, or a tautomer or a pharmaceutically acceptable salt thereof, and cisplatin.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.38462
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14356232', '14131183', '14355684', '12604970', '12601729']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7656739920690356
- 35 USC 102 Novelty (BERT): 0.5485175253236823
- Combined Prediction Score: 0.7439583453945002
- Mean Citation Score: 369.691532
- Max Citation Score: 430.3388
- Similarity Product: 349.29543025345805

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test